Speakers

Jeremy Abbate

Publisher

Scientific American

Wade Ackerman

Partner

Covington & Burling LLP

Gautam Aggarwal

Partner

Triangle Insights Group, LLC

Aparna Ahuja

CMO

T2 Biosystems

Querida Anderson

Managing Editor

FierceBiotech, Healthcare, Medtech & Pharma

Robert Ang

CEO

Vor Biopharma

Jill Angelo

CEO

Gennev

Jim Anthony

EVP and Global Head

Parexel Biotech

Mara Aspinall

Managing Director

Health Catalysts Group

Phyllis Barkman Ferrell

Global Head, External Engagement, Alzheimer’s disease and Neurodegeneration

Eli Lilly & Company

Harold Bernstein

Chief Medical Officer and SVP

BioMarin

Esther Bleicher

Chief Counsel, Therapeutics and Product & Technology

Valo Health

Travis Bond

CEO

Altoida, Inc.

Ben Bonifant

Partner

Triangle Insights

Rick Bright

CEO, Pandemic Prevention Institute & Senior VP, Pandemic Prevention & Response, Health Initiative

The Rockefeller Foundation

Christoph Broja

Principal

Gurnet Point Capital

Michael Brooks

Chief Development Officer and Global Head, Clinical Development Solutions

Syneos Health

Steve Brozak

President

WBB Securities LLC

Tom Burns

Senior VP, Finance and CFO

XOMA

Susan Cantrell

CEO

Academy of Managed Care Pharmacy (AMCP)

Gabriel P. Cavazos

Senior Managing Director, Investment Banking

SVB Leerink

Michelle Chen

CBO

Insilico Medicine

Erik Clausen

Managing Partner

CG Life

Jason Cole

CBO

bluebird bio

Karin Conde-Knape

Senior VP Global Drug Discovery

Novo Nordisk

Everett Crosland

CCO

Cognito Therapeutics

Alice Valder Curran

Partner

Hogan Lovells

Michael Davitian

VP

Health Advances

Kevin DeGeeter

Managing Director, Healthcare Research

Oppenheimer & Co. Inc.

Sara Jane Demy

CEO and Founder

Demy-Colton

Bob Dougherty

VP, Digital Health Research

COMPASS Pathways

Doug Drysdale

CEO

Cybin

Andy Dunn

Senior Biopharma Reporter

Business Insider

Keith Fern

VP, Strategic Partnerships

Elligo Health Research

Simone Fishburn

VP and Editor in Chief

BioCentury

Michael Fitzhugh

Managing Editor

BioWorld

Osvaldo Flores

CEO

Century Therapeutics

Mani Foroohar

Managing Director, Senior Research Analyst

Leerink Partners

Maria Fotiu

Executive VP of Decentralized Solutions

Syneos Health

Bobby Gaspar

CEO

Orchard Therapeutics

Adam Gazzaley

David Dolby Distinguished Professor of Neurology, Physiology & Psychiatry

UC San Francisco

Jennifer Friel Goldstein

Managing Partner, Life Science and Healthcare

SVB Capital

Miranda Gottlieb

Venture Partner

Pappas Capital

Walter Greenleaf

Distinguished Visiting Scholar

Stanford University’s MediaX Program

Ted Haack

VP

Lattice Point Consulting

Katya Hancock

Investment Network Director

StartUp Health

Paul J. Hastings

President and CEO

Nkarta Therapeutics, Inc.

Kevin Healy

Senior VP, Regulatory Affairs, Pharmacovigilance, and Quality

Enzyvant

William Ho

CEO

In8bio

Beth Hoffman

Founder and CEO

Origami Therapeutics, Inc.

Alison Holland

Head of Decentralized and Remote Trials

Medable

Chihiro Hosoya

Head of Venture Management and Business Development

Astellas Rx+ Business Accelerator

Juliet Hulse

Senior Director, Global RN Strategy and Patient Advocacy

Illingworth Research Group™, a Syneos Health Company, USA

Mandy Jackson

Managing Editor, US Commercial News

Scrip/The Pink Sheet

Rachelle Jacques

CEO

Enzyvant

Alan Jiang

CSO

XtalPi Inc.

Ben Johnson

Head of Early Stage Life Science

Silicon Valley Bank

Bryan Katz

Senior VP and Global Head, Solution Development

Syneos Health

Elizabeth Kelly

Fund Manager

Asia Innovation Ventures

Steven Kelly

President and CEO

CARISMA Therapeutics

David J. Kim

Managing Director

DigiTx Partners

Susan Kitlas

VP, Precommercial Segment Lead

IQVIA

Lina Kontos

Partner

Hogan Lovells

Suma Krishnan

Founder and COO

Krystal Biotech

Janet Lambert

CEO

Alliance for Regenerative Medicine

Tomas Landh

Innovation Sourcing VP, Senior Principal Scientist, R&D Global Search & Evaluation

Novo Nordisk

Francesco Lavino

CEO

F2G

Martin Lehr

CEO and Director

Context Therapeutics

Ron Leuty

Biotech Reporter

San Francisco Business Journal

Jeremy Levin

CEO and Board of Directors Chair

Ovid Therapeutics, BIO

Yuwen Liu

Founding Partner and Founder

BOHE Angel Fund, Bio2

Michelle Longmire

CEO and Co-Founder

Medable

Philippe Lopes-Fernandes

Executive VP and CBO

Ipsen

Jamie Macdonald

CEO

Parexel

Yuri Maricich

CMO and Head of Development

Pear Therapeutics

Todd Matthews

Senior Director

Corporate Alliances, IQVIA

Mariana Matus

CEO and Co-Founder

Biobot Analytics

Matt McCarthy

Hospitalist, Weill Cornell Medical Center; Associate Attending Physician, New York-Presbyterian Hospital; Associate Professor of Medicine, Weill Cornell Medical College

Cornell University

Owen McCarthy

President and Founder

MedRhythms

John McDonald

Corporate VP, Global R&D Business Development

Novo Nordisk

Michael McFadden

CEO

Alpha Cognition, Inc.

Michelle McMurry-Heath

President and CEO

Biotechnology Innovation Organization (BIO)

Andrew Meadow

General Partner

Health Innovation Capital

Matt Miller

CEO

StudyKIK

Alison Moore

Chief Technical Officer

Allogene Therapeutics

David Moore

Partner

Gurnet Point Capital

Bibhash Mukhopadhyay

Former Principal

New Enterprise Associates

Naveen Murthy

Senior Managing Director, Head of Product & Franchise Strategy, Commercial Advisory Group, Consulting

Syneos Health

Marian Nakada

VP, Venture Investments

Johnson & Johnson Innovation, JJDC

James R. Neal

CEO and Member, Board of Directors

XOMA

Jennifer Newberger

VP Head of Regulatory Affairs and Compliance

Cognito Therapeutics

Emile Nuwaysir

CEO, Ensoma; Chairman, Alliance for Regenerative Medicine (ARM); Chairman, CEO

BlueRock Therapeutics

Crystal Nyitray

CEO

Encellin

Robert O'Brien

VP

Real Endpoints

Tim Opler

Partner & Co-Founder

Torreya

Art Pappas

Managing Partner

Pappas Capital

Bakul Patel

Director of Digital Health Center of Excellence

Food and Drug Administration

Neel Patel

Executive Managing Director, Head Commercial Advisory Group - Consulting

Syneos Health Consulting

Kelliann Payne

Partner

Hogan Lovells

Tanya Petrossian

CEO

EndoCyclic Therapeutics

Catherine Phillips

Innovation Architect

Heathrow Airport

Karen Pihel

Senior Director, CMC Regulatory Affairs

Enzyvant

Logan Plaster

Director and Editor-in-Chief

StartUp Health

Myrtle Potter

CEO

Sumitovant

Dennis J. Purcell

Founder and Senior Advisor

Aisling Capital

Sachin Purwar

Director of Commercial Advisory Group, Consulting

Syneos Health

Kanya Rajangam

CMO

Nkarta Therapeutics

Lisa Ricciardi

CEO

Cognition Therapeutics, Inc.

Liz Rockett

Managing Director

Kaiser Permanente Ventures

Beth Rogozinski

CEO

Oncoustics

Spiro Rombotis

President and CEO

Cyclacel Pharmaceuticals

Peter Rubin

Executive Director

No Patient Left Behind

Camille Samuels

Partner

Venrock

Michael Sarshad

Director of Commercial Advisory Group, Consulting

Syneos Health

Sam Scarpino

Managing Director, Pathogen Surveillance

Pandemic Prevention Institute

Greg Scott

Founder and Chairman

ChinaBio® Group

Nadeem Sheikh

VP, Research and Manufacturing Sciences

Dendreon

Shmuel Shoham

Associate Professor of Medicine

Johns Hopkins University School of Medicine

Ed Silverman

Senior Writer and Pharmalot Columnist

STAT

Steven Q. Simpson

Professor of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kansas, and 83rd President of the American College of Chest Physicians

,

Bob Smith

SVP, Global Gene Therapy Business

Pfizer Inc.

Juliane Snowden

Founder

The Oratorium Group

Komathi Stem

COO

Glooko

Helen Stembridge

UKHSA Strategic Engagement and Director of Projects

WholeShip Consulting Ltd

Andrew Strong

Partner

Hogan Lovells

Valentin Tablan

Chief AI Officer

ieso Digital Health

Weimin Tang

CBO

I-Mab Biopharma

Victor E. Tong

Partner

Decheng Capital

Christian Tucat

President

Syneos One and Real World Evidence

John Vandermosten

Senior Biotechnology Analyst

Zacks Investment Research

Brent Vaughan

CEO

Cognito Therapeutics

Thomas J. Walsh

Director, Institute for Innovative Therapeutics and Diagnostics; Henry Schueler Foundation Scholar in Mucormycosis; Investigator, Emerging Infectious Diseases,

Save Our Sick Kids

Larry Weiner

VP of Pharmaceutical Development & Manufacturing

Enzyvant

Eugene Williams

Chairman and CEO

ProMIS Neurosciences

Anton Xavier

Director

Silicon Valley Bank

Mylene Yao

CEO

Univfy

Berra Yazar-Klosinski

CSO

Multidisciplinary Association for Psychedelic Studies (MAPS)

Debra Yu

President and CSO

LianBio

Lihua Zheng

CBO and Co-Founder

AnHeart Therapeutics

Maryam Ziaei-Moayyed

CEO

iSono Health